Melanotan II
Animal studies onlyAlmost all the research is in animals. We do not know if the same thing happens in people.
Also called MT-2 / MT-II / Melanotan 2
A lab-made peptide that darkens skin. It is not approved anywhere and has well-documented side effects.
The basics
- What is it?
- A lab-made peptide that switches on the pathway that darkens skin.
- What do we know?
- It does darken skin, and it has clear side effects such as nausea, blood pressure changes and new or changing moles.
- What do we still not know?
- Almost everything about safety over time. It is not approved anywhere and is sold only on the grey market.
Can a doctor prescribe this?
No. It was reviewed and turned down.
The FDA has not approved this as a medicine.
Not approved anywhere and declined for the 503A bulks list.
Official status: Declined for the 503A bulks list. Checked 2026-04-22.
Lab suppliers we list: 12
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
In animal studies
These are doses given to animals, usually per kilogram of body weight. They do not convert directly to a human dose.
60 nmol/kg
rats · another route · daily
Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.European journal of pharmacology · 2024
“Stressed and control male adult Sprague-Dawley rats received daily intraperitoneal injections of saline or a low dose (60 nmol/kg of body weight (BW)) of Semax or MTII.”
1 nmol
mice ·
Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food.Neuropeptides · 2022
“Methods Male, C57BL/6J mice were microinjected bilaterally into the NAcc (100 nl/side) with the melanocortin receptor 3/4 agonist melanotan-II (MT-II; 0.1, 0.3, and 1 nmol), and ingestive behaviors were examined in both home cage and operant food self-administration experiments.”
1 nmol
mice ·
Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for foodJournal not recorded · 2022
“Methods Male, C57BL/6J mice were microinjected bilaterally into the NAcc (100 nl/side) with the melanocortin receptor 3/4 agonist melanotan-II (MT-II; 0.1, 0.3, and 1 nmol), and ingestive behaviors were examined in both home cage and operant food self-administration experiments.”
0.26 mg/kg
mice ·
Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.Alcoholism, clinical and experimental research · 2015
“Results Both NAL and MTII blunt binge-like EtOH drinking and associated blood EtOH levels, and when administered together, a low dose of MTII (0.26 mg/kg) produces a 7.6-fold increase in the effectiveness of NAL in reducing binge-like EtOH drinking.”
1 mcg
mice · into a vein
The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice.Neuropeptides · 2014
“Wild-type MC3R+/+ and MC3R-/- mice were given intracerebroventricular (i.c.v.) infusion of MTII (0.0, 0.25, 0.50, or 1.0 μg) prior to the onset of a 4-h testing period in which mice were given access to 20% (v/v) ethanol.”
See source wording
mice ·
Food intake reductions and increases in energetic responses by hindbrain leptin and melanotan II are enhanced in mice with POMC-specific PTP1B deficiency.American journal of physiology. Endocrinology and metabolism · 2012
“Therefore, we examined the effects of hindbrain administration (4th ventricle) of leptin (1.5, 3, and 6 μg) or the melanocortin 3/4R agonist melanotan II (0.1 and 0.2 nmol) in POMC-Ptp1b(-/-) (KO) and control PTP1B(fl/fl) (WT) mice on food intake, body weight, spontaneous physical activity (SPA), and core temperature (T(C)).”
See source wording
rats ·
5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.European journal of pharmacology · 2008
“SB200646 at 10 mg/kg and SB242084 at 3 mg/kg, these doses which completely antagonize penile erections induced by 5-HT(2C) receptor agonists, m-chlorophenylpiperazine (mCPP) and (S)-2-(7-ethyl-1H-furo[2,3-g]indazol-1-yl)-1-methylethylamine (YM348), significantly inhibited penile erections elicited by apomorphine, oxytocin or MT-II.”
2 mg/kg
rats · single dose
Effects of melanotan II, a melanocortin agonist, on grooming and exploration in rats after repeated restraint/immobilization.Neuroscience letters · 2008
“2mg/kg melanotan II (MTII, administered i.p.), a cyclic peptide analog of alpha-melanocyte stimulating hormone, at a single dose increased grooming in naive rats placed in an unfamiliar open-field device without changing locomotion or rearing.”
3 mg/kg
rats · into a vein
The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat.Pharmacology, biochemistry, and behavior · 2006
“MT-II (1 and 3 mg/kg) or saline was injected intravenously 10 min before each 30-min paced mating test.”
1 mg/kg
rats ·
Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized rat.Neuroscience · 2006
“(0.1, 0.3 and 1 mg/kg) or within the paraventricular nucleus of the hypothalamus (0.1 and 1 microg), melanotan-II exerted a dose-dependent inducer activity on erection by eliciting erectile events and shortening latency of the first erectile event to occur.”
1 mg/kg
rats · into a vein
The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II) in conscious rats.European urology · 2005
“Methods Adult rats were implanted in the corpus cavernosum with a pressure sensor which permitted telemetric monitoring of ICP in freely moving animals following MT-II (0.1, 0.3 and 1 mg/kg) or saline i.v.”
225 ng
mice · into a vein
Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice.Diabetologia · 2005
“Methods Over a period of 24 h, 225 ng of MTII was injected in three aliquots into the left lateral ventricle of male C57Bl/6 mice.”
- Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.
Animal study, rats or mice
European journal of pharmacology · 2024
- Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.
Animal study, rats or mice
Endocrinology · 2024
- Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food.
Animal study, rats or mice
Neuropeptides · 2022
- Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food
Animal study, rats or mice
Journal not recorded · 2022
- Melanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase-activating polypeptide deficient mice.
Animal study, rats or mice
Experimental physiology · 2021
- Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism.
Animal study, rats or mice
PloS one · 2019
- Effect of Melanotan-II on Brain Fos Immunoreactivity and Oxytocin Neuronal Activity and Secretion in Rats.
Animal study, rats or mice
Journal of neuroendocrinology · 2017
- Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.
Animal study, rats or mice
Alcoholism, clinical and experimental research · 2015
- Inhibitory Effect of the Melanocortin Receptor Agonist Melanotan-II (MTII) on Feeding Depends on Dietary Fat Content and not Obesity in Rats on Free-Choice Diets.
Animal study, rats or mice
Frontiers in behavioral neuroscience · 2015
- The medial preoptic nucleus as a site of the thermogenic and metabolic actions of melanotan II in male rats.
Animal study, rats or mice
American journal of physiology. Regulatory, integrative and comparative physiology · 2014
- The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice.
Animal study, rats or mice
Neuropeptides · 2014
- Food intake reductions and increases in energetic responses by hindbrain leptin and melanotan II are enhanced in mice with POMC-specific PTP1B deficiency.
Animal study, rats or mice
American journal of physiology. Endocrinology and metabolism · 2012
- 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Animal study, rats or mice
European journal of pharmacology · 2008
- Effects of melanotan II, a melanocortin agonist, on grooming and exploration in rats after repeated restraint/immobilization.
Animal study, rats or mice
Neuroscience letters · 2008
- Effects of ghrelin, corticotrophin-releasing hormone, and melanotan-II on food intake in rats with paraventricular nucleus lesions.
Animal study, rats or mice
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2007
- The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat.
Animal study, rats or mice
Pharmacology, biochemistry, and behavior · 2006
- Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized rat.
Animal study, rats or mice
Neuroscience · 2006
- The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II) in conscious rats.
Animal study, rats or mice
European urology · 2005
- Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice.
Animal study, rats or mice
Diabetologia · 2005
- Melanotan II causes hypothermia in mice by activation of mast cells and stimulation of histamine 1 receptors.
Lab dish study
American journal of physiology. Endocrinology and metabolism · 2018
- Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.
Lab dish study
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2011
- Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.
Life (Basel, Switzerland) · 2026
- 5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.
Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
- Barbie drug identification: Not a child's play.
Journal of forensic sciences · 2024
- Melanotan-II reverses memory impairment induced by a short-term HF diet.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
- CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.
Journal of medicinal chemistry · 2022
- Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.
Dermatology (Basel, Switzerland) · 2021
- LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs.
Drug testing and analysis · 2021
- Combining MALDI mass spectrometry imaging and droplet-base surface sampling analysis for tissue distribution, metabolite profiling, and relative quantification of cyclic peptide melanotan II.
Analytica chimica acta · 2020
- Melanotan II: a possible cause of renal infarction: review of the literature and case report.
CEN case reports · 2020
- The unregulated use of melanotan-II is of public health interest to Australian dermatologists.
The Australasian journal of dermatology · 2017
- Analogue of Melanotan II (MTII): A Novel Melanotropin with Superpotent Action on Frog Skin.
Protein and peptide letters · 2015
- Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet.
Drug testing and analysis · 2015
- Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
European journal of dermatology : EJD · 2014
- Melanoma associated with the use of melanotan-II.
Dermatology (Basel, Switzerland) · 2014
- [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
Lakartidningen · 2013
- Melanotan II overdose associated with priapism.
Clinical toxicology (Philadelphia, Pa.) · 2013
- [Dermoscopic changes in melanocytic nevi during use of melanotan II].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2012
- Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
Clinical toxicology (Philadelphia, Pa.) · 2012
- The first preparative solution phase synthesis of melanotan II.
Beilstein journal of organic chemistry · 2008
- Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?
Review of earlier work
International journal of oral and maxillofacial surgery · 2025
- Response to letter to the editor regarding "melanotan II injection resulting in systemic toxicity and rhabdomyolysis" in Clinical Toxicology 2012; 50(10):1169-73.
Review of earlier work
Clinical toxicology (Philadelphia, Pa.) · 2013